Is human oversight to AI systems still possible?

IF 4.5 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS
Andreas Holzinger, Kurt Zatloukal, Heimo Müller
{"title":"Is human oversight to AI systems still possible?","authors":"Andreas Holzinger, Kurt Zatloukal, Heimo Müller","doi":"10.1016/j.nbt.2024.12.003","DOIUrl":null,"url":null,"abstract":"<p><p>The rapid proliferation of artificial intelligence (AI) systems across diverse domains raises critical questions about the feasibility of meaningful human oversight, particularly in high-stakes domains such as new biotechnology. As AI systems grow increasingly complex, opaque, and autonomous, ensuring responsible use becomes a formidable challenge. During our editorial work for the special issue \"Artificial Intelligence for Life Sciences\", we placed increasing emphasis on the topic of \"human oversight\". Consequently, in this editorial we briefly discuss the evolving role of human oversight in AI governance, focusing on the practical, technical, and ethical dimensions of maintaining control. It examines how the complexity of contemporary AI architectures, such as large-scale neural networks and generative AI applications, undermine human understanding and decision-making capabilities. Furthermore, it evaluates emerging approaches-such as explainable AI (XAI), human-in-the-loop systems, and regulatory frameworks-that aim to enable oversight while acknowledging their limitations. Through a comprehensive analysis, the picture emerged while complete oversight may no longer be viable in certain contexts, strategic interventions leveraging human-AI collaboration and trustworthy AI design principles can preserve accountability and safety. The discussion highlights the urgent need for interdisciplinary efforts to rethink oversight mechanisms in an era where AI may outpace human comprehension.</p>","PeriodicalId":19190,"journal":{"name":"New biotechnology","volume":" ","pages":"59-62"},"PeriodicalIF":4.5000,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1016/j.nbt.2024.12.003","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

The rapid proliferation of artificial intelligence (AI) systems across diverse domains raises critical questions about the feasibility of meaningful human oversight, particularly in high-stakes domains such as new biotechnology. As AI systems grow increasingly complex, opaque, and autonomous, ensuring responsible use becomes a formidable challenge. During our editorial work for the special issue "Artificial Intelligence for Life Sciences", we placed increasing emphasis on the topic of "human oversight". Consequently, in this editorial we briefly discuss the evolving role of human oversight in AI governance, focusing on the practical, technical, and ethical dimensions of maintaining control. It examines how the complexity of contemporary AI architectures, such as large-scale neural networks and generative AI applications, undermine human understanding and decision-making capabilities. Furthermore, it evaluates emerging approaches-such as explainable AI (XAI), human-in-the-loop systems, and regulatory frameworks-that aim to enable oversight while acknowledging their limitations. Through a comprehensive analysis, the picture emerged while complete oversight may no longer be viable in certain contexts, strategic interventions leveraging human-AI collaboration and trustworthy AI design principles can preserve accountability and safety. The discussion highlights the urgent need for interdisciplinary efforts to rethink oversight mechanisms in an era where AI may outpace human comprehension.

人类对人工智能系统的监督还有可能吗?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
New biotechnology
New biotechnology 生物-生化研究方法
CiteScore
11.40
自引率
1.90%
发文量
77
审稿时长
1 months
期刊介绍: New Biotechnology is the official journal of the European Federation of Biotechnology (EFB) and is published bimonthly. It covers both the science of biotechnology and its surrounding political, business and financial milieu. The journal publishes peer-reviewed basic research papers, authoritative reviews, feature articles and opinions in all areas of biotechnology. It reflects the full diversity of current biotechnology science, particularly those advances in research and practice that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion and comment on broader issues of general interest and concern. The outlook is fully international. The scope of the journal includes the research, industrial and commercial aspects of biotechnology, in areas such as: Healthcare and Pharmaceuticals; Food and Agriculture; Biofuels; Genetic Engineering and Molecular Biology; Genomics and Synthetic Biology; Nanotechnology; Environment and Biodiversity; Biocatalysis; Bioremediation; Process engineering.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信